Skip to main content
Veterinary Medicines

Nobivac Respira Bb vet. suspension for injection in pre-filled syringe for dogs

Authorised
  • Bordetella bronchiseptica, strain Bb7 92932, fimbriae

Product identification

Medicine name:
Nobivac Respira Bb vet. suspension for injection in pre-filled syringe for dogs
Nobivac Respira Bb suspensija injekcijām pilnšļircē suņiem
Active substance:
  • Bordetella bronchiseptica, strain Bb7 92932, fimbriae
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain Bb7 92932, fimbriae
    88.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection in pre-filled syringe
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AE02
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/DCP/20/0055
Date of authorisation status change:
Reference member state:
  • Denmark
Procedure number:
  • DK/V/0123/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 23/03/2023

PI.pdf

English (PDF)
Published on: 27/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."